Rogic, Anita http://orcid.org/0000-0001-6750-5159
Pant, Ila http://orcid.org/0000-0003-0517-6542
Grumolato, Luca http://orcid.org/0000-0001-8231-3032
Fernandez-Rodriguez, Ruben http://orcid.org/0000-0001-9127-1735
Edwards, Andrew
Das, Suvendu
Sun, Aaron http://orcid.org/0000-0002-5773-3382
Yao, Shen
Qiao, Rui
Jaffer, Shabnam http://orcid.org/0000-0001-9843-7427
Sachidanandam, Ravi
Akturk, Guray http://orcid.org/0000-0001-7032-8085
Karlic, Rosa http://orcid.org/0000-0002-1291-2897
Skobe, Mihaela http://orcid.org/0000-0003-1583-6487
Aaronson, Stuart A. http://orcid.org/0000-0002-4643-0474
Funding for this research was provided by:
Eli Lilly and Company
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01CA80058, R01CA170702, U01 OHO11328)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Breast Cancer Research Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 1 September 2020
Accepted: 2 November 2021
First Online: 25 November 2021
Competing interests
: The authors declare no competing interests.